Lexmark SLIDES Due to Lack of Demand and 3 Mid-Week Stock Analyses to Note

NXP Semiconductors NV (NASDAQ:NXPI) is recommended to be bought on weakness by Sterne Agee. The firm stated the the company had a solid Q2 and that slowing gross margin improvement was because of new product design ramps.

Sarepta Therapeutics Inc. (:SRPT) price target was increased after  positive eteplirsen data in Duchenne Muscular Dystrophy.

Don’t Miss: Jim Cramer: Buy Apple NOW!

Sanofi-Aventis (NYSE:SNY): Deutsche Bank thinks that a warning letter sent to Sanofi from the FDA which documents deficiencies in good manufacturing practices at the company’s Toronto, Canada and Marcy L’Etolie, France vaccine production sites will not have much affect on sales. The firm maintains its Buy rating on the stock.

Lexmark International Inc. (NYSE:LXK) estimates were cut by Deutsche Bank due to deteriorating demand conditions. Shares have a Hold rating.

Celanese Corp. (NYSE:CE) price target was reduced because of its cautious outlook, but the firm still views risk/reward as favorable. Shares have a Buy rating.

Don’t Miss: Can Google FINALLY Breathe Easier in Europe?

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Premium Newsletters

Stock Investor Cheat Sheet

Stock Investor Cheat Sheet®

The ultimate Cheat Sheet for finding winning stock picks.
Learn More

Gold & Silver Newsletter

Gold & Silver

Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
Learn More

Commodities Premium Newsletter

Commodities Premium

There's always a bull market in some sector! Find the best opportunities in commodities.
Learn more

ETF Investing

ETF Investing

At last, a trading system that buys the right ETFs at the right time, time after time!
Learn more

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business